BLEOMYCIN, CISPLATIN
GinOnc-ECT
Phase 2 small_molecule active
Quick answer
BLEOMYCIN, CISPLATIN for patients with newly diagnosed or recurrent high-grade or initially invasive precancerous squamous lesions of the vulva and non-invasive vulvar Paget's disease is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- patients with newly diagnosed or recurrent high-grade or initially invasive precancerous squamous lesions of the vulva and non-invasive vulvar Paget's disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active